Altamira Therapeutics Ltd. Rightofuse Assets
Altamira Therapeutics Ltd. (CYTOF) had Rightofuse Assets of $327.69 thousand as of 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Notes
ifrs-full:RightofuseAssets · last filed 2025-08-29
- 2023-12-31: Rightofuse Assets 80.11K CHF.
- 2023-06-30: Rightofuse Assets 387.74K CHF.
- 2022-12-31: Rightofuse Assets 445.83K CHF.
- 2022-06-30: Rightofuse Assets 505.27K CHF.
CHF
| Period end | Rightofuse Assets |
|---|---|
| 2023-12-31 | 80.11K CHF 20-F/A · filed 2024-04-22 |
| 2023-06-30 | 387.74K CHF 6-K · filed 2023-09-12 |
| 2022-12-31 | 445.83K CHF 20-F/A · filed 2024-04-22 |
| 2022-06-30 | 505.27K CHF 6-K/A · filed 2023-08-21 |
| 2021-12-31 | 564.71K CHF 6-K/A · filed 2023-08-21 |
USD
| Period end | Rightofuse Assets |
|---|---|
| 2025-06-30 | $327.69K 6-K · filed 2025-08-29 |
| 2024-12-31 | $349.90K 6-K · filed 2025-08-29 |
| 2024-06-30 | $417.62K 6-K · filed 2024-09-24 |
| 2023-12-31 | $95.20K 20-F · filed 2025-04-30 |
| 2023-01-01 | $481.92K 20-F · filed 2025-04-30 |